- Home
- ATHA vs MXC Comparison
ATHA vs MXC Comparison
Compare ATHA & MXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATHA
- MXC
- Stock Information
- Founded
- ATHA 2011
- MXC 1972
- Country
- ATHA United States
- MXC United States
- Employees
- ATHA N/A
- MXC N/A
- Industry
- ATHA Medicinal Chemicals and Botanical Products
- MXC Oil & Gas Production
- Sector
- ATHA Health Care
- MXC Energy
- Exchange
- ATHA Nasdaq
- MXC Nasdaq
- Market Cap
- ATHA 21.0M
- MXC 23.5M
- IPO Year
- ATHA 2020
- MXC N/A
- Fundamental
- Price
- ATHA $0.53
- MXC $11.86
- Analyst Decision
- ATHA Buy
- MXC
- Analyst Count
- ATHA 4
- MXC 0
- Target Price
- ATHA $11.25
- MXC N/A
- AVG Volume (30 Days)
- ATHA 235.4K
- MXC 23.8K
- Earning Date
- ATHA 02-20-2025
- MXC 02-07-2025
- Dividend Yield
- ATHA N/A
- MXC 0.84%
- EPS Growth
- ATHA N/A
- MXC N/A
- EPS
- ATHA N/A
- MXC 0.57
- Revenue
- ATHA N/A
- MXC $6,926,917.00
- Revenue This Year
- ATHA N/A
- MXC N/A
- Revenue Next Year
- ATHA N/A
- MXC N/A
- P/E Ratio
- ATHA N/A
- MXC $20.83
- Revenue Growth
- ATHA N/A
- MXC N/A
- 52 Week Low
- ATHA $0.41
- MXC $9.41
- 52 Week High
- ATHA $4.30
- MXC $16.52
- Technical
- Relative Strength Index (RSI)
- ATHA 41.88
- MXC 49.24
- Support Level
- ATHA $0.52
- MXC $11.35
- Resistance Level
- ATHA $0.57
- MXC $13.40
- Average True Range (ATR)
- ATHA 0.04
- MXC 0.73
- MACD
- ATHA -0.00
- MXC 0.06
- Stochastic Oscillator
- ATHA 11.82
- MXC 35.34
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) a subcutaneously administered, small molecule positive modulator of the HGF/MET system for CNS disorders, ATH-1020 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system. ATH-1105 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system, and several other compounds in preclinical discovery and development for neurodegenerative diseases, including ATH-1018 and ATH-1019.
About MXC Mexco Energy Corporation
Mexco Energy Corporation is an independent oil and gas company. It is engaged in the exploration, development, and production of natural gas and crude oil properties located in the United States. The company carried out its operation in the Permian Basin of West Texas. It is focusing on two primary areas, the Delaware Basin located in the Western portion of the Permian Basin including Lea and Eddy Counties, New Mexico and Loving County, Texas, and the Midland Basin located in the Eastern portion of the Permian Basin including Reagan, Upton, Midland, Martin, Howard, and Glasscock Counties, Texas. The company generates revenue from Oil sales, Natural gas sales, oil and gas royalty interests.